SNAP47 Activators are compounds that either directly or indirectly enhance the functional activity of SNAP47, a protein that is a key component of the SNARE complex involved in vesicular trafficking and neurotransmitter release. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C which can enhance the activity of SNAP47 by promoting its phosphorylation, thereby facilitating its role in vesicle docking and neurotransmitter release. Forskolin, by increasing intracellular cAMP levels, leads to the activation of PKA which can phosphorylate proteins associated with vesicular trafficking, indirectly enhancing SNAP47's function in the process.
Okadaic Acid, a PP2A inhibitor, maintains the phosphorylation state of various proteins, which could keep SNAP47 in an enhanced functional state by preventing its dephosphorylation. N-Ethylmaleimide (NEM), by inhibiting NSF, stabilizes SNARE complexes that include SNAP47, thus enhancing its function in vesicle docking and fusion. Similarly, Calyculin A, by inhibiting phosphatases like PP1 and PP2A, can maintain the phosphorylation state of SNAP47, enhancing its interaction with other SNARE proteins. H-89, through its inhibitory action on PKA, might indirectly increase the functional demand on SNAP47 by necessitating more SNARE-mediated vesicular transport to compensate for inhibited PKA-dependent pathways. Brefeldin A disrupts ARF function, which could lead to enhanced SNAP47 activity as the cell compensates for disturbed Golgi function and vesicle formation. Ionomycin and Thapsigargin, both of which elevate cytosolic calcium levels, enhance SNAP47's role in calcium-dependent vesicle fusion processes. Monensin, by disrupting sodium ion gradients, could indirectly enhance the functional activity of SNAP47 by affecting vesicular trafficking. Tetanus toxin, which cleaves SNARE proteins, might increase the functional demand on intact SNAP47 for the formation of SNARE complexes. Lastly,Alpha-Latrotoxin, by triggering neurotransmitter release, could indirectly necessitate increased activity of SNAP47 to handle the heightened need for SNARE-mediated vesicular trafficking.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C activator that phosphorylates SNAP47, leading to its enhanced interaction with SNARE complex components, facilitating vesicle docking and neurotransmitter release. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels, indirectly enhancing SNAP47 by promoting PKA activation which can phosphorylate proteins associated with vesicular transport. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
PP2A inhibitor that prevents dephosphorylation of proteins involved in vesicular trafficking, potentially maintaining SNAP47 in a phosphorylated state, enhancing its function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibitor of PP1 and PP2A phosphatases, maintaining phosphorylation states of proteins; this can indirectly enhance SNAP47 activity by stabilizing its association with SNARE complexes. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
PKA inhibitor that indirectly enhances SNAP47 by increasing the demand for compensatory SNARE-mediated vesicular transport when PKA-dependent pathways are inhibited. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of ADP-ribosylation factor (ARF), disturbing Golgi apparatus function and vesicle formation; this stress may indirectly enhance SNAP47 function by necessitating more efficient SNARE-mediated vesicular trafficking. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore that increases intracellular calcium levels, promoting vesicle fusion events where SNAP47 is functionally important. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that raises cytosolic calcium levels, similarly to Ionomycin, indirectly enhancing SNAP47 function in calcium-dependent vesicle fusion. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Sodium ionophore that disrupts trans-Golgi network function, potentially enhancing the role of SNAP47 in compensatory vesicular trafficking mechanisms. | ||||||